Highlights Aligned with the FDA in two Positive Type C meetings supporting key elements of the planned Phase 3 program for ATH434 in MSAAdvancing ...

Pomerantz LLP is investigating claims on behalf of investors of Theravance Biopharma, Inc. ("Theravance" or the "Company") .  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.

Kodiak Sciences Inc. , a precommercial retina-focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, today announced it will present ...

Senate Bill 4834 would remove testosterone from the state’s Prescription Monitoring Program, a database created to track ...

On February 24, 2026, engineers at NASA’s Jet Propulsion Laboratory fed liquid lithium into a prototype plasma thruster, ...

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that causes the progressive loss of motor neurons, which ...

For nearly 25 years, scientists believed they knew what caused the most severe form of narcolepsy. A new UCLA Health study ...

It often begins with a diagnosis; just a name on paper, something clinical and distant. But behind that name can be stories ...

Sarcopenia is a major feature of ageing and is characterized by a progressive decline in skeletal muscle mass, strength, and functional capacity. While ...

The U.S. health system is at a pivotal moment as rising costs, persistent inequities, and uneven outcomes expose the ...